Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19

MLA

Helison Rafael P. Carmo, et al. “Phenotypic Changes in Low-Density Lipoprotein Particles as Markers of Adverse Clinical Outcomes in COVID-19.” Molecular Genetics and Metabolism, vol. 138, Apr. 2023, p. 107552. EBSCOhost, https://doi.org/10.1016/j.ymgme.2023.107552.

APA

Helison Rafael P. Carmo, Marcos Y. Yoshinaga, Alejandro Rosell Castillo, Adriano Britto Chaves-Filho, Isabella Bonilha, Joaquim Barreto, Stéfanie Primon Muraro, Gabriela Fabiano de Souza, Gustavo Gastão Davanzo, Maurício W. Perroud, Kishal Lukhna, Mpiko Ntsekhe, Sean Davidson, Licio A. Velloso, Wilson Nadruz, Luiz Sérgio F. Carvalho, Miguel Sáinz-Jaspeado, Alessandro S. Farias, José Luiz Proença-Módena, … Andrei C. Sposito. (2023). Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19. Molecular Genetics and Metabolism, 138, 107552. https://doi.org/10.1016/j.ymgme.2023.107552

Chicago

Helison Rafael P. Carmo, Marcos Y. Yoshinaga, Alejandro Rosell Castillo, Adriano Britto Chaves-Filho, Isabella Bonilha, Joaquim Barreto, Stéfanie Primon Muraro, et al. 2023. “Phenotypic Changes in Low-Density Lipoprotein Particles as Markers of Adverse Clinical Outcomes in COVID-19.” Molecular Genetics and Metabolism 138 (April): 107552. doi:10.1016/j.ymgme.2023.107552.